Complete remission in a patient with JAK2- and IDH2-positive myelofibrosis.
Department of Leukemia and.
Lucia
L
Masarova
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Wei
W
Wang
Department of Leukemia and.
Kate J
KJ
Newberry
Department of Leukemia and.
Hagop
H
Kantarjian
Department of Leukemia and.
Srdan
S
Verstovsek
D005260:Female; D006801:Humans; D007521:Isocitrate Dehydrogenase / Q000235:genetics*; D053614:Janus Kinase 2 / Q000235:genetics*; D008875:Middle Aged; D009154:Mutation; D009570:Nitriles; D055728:Primary Myelofibrosis / Q000188:drug therapy* / Q000235:genetics; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines; D012074:Remission Induction; D016896:Treatment Outcome
D009570:Nitriles; D011720:Pyrazoles; D011743:Pyrimidines; C540383:ruxolitinib; C538784:IDH2 protein, human; D007521:Isocitrate Dehydrogenase; C507924:JAK2 protein, human; D053614:Janus Kinase 2